[1] |
Baumgartner H, Bonhoeffer P, De Groot NM, et al. ESC guidelines for the management of grown-up congenital heart disease(new version 2010)[J]. Eur Heart J, 2010, 31(23): 2915-2957.
doi: 10.1093/eurheartj/ehq249
pmid: 20801927
|
[2] |
Sousa JE, Costa MA, Tuzcu EM, et al. New frontiers in interventional cardiology[J]. Circulation, 2005, 111(5): 671-681.
doi: 10.1161/01.CIR.0000153802.70682.22
|
[3] |
Fu Y-C, Bass J, Amin Z, et al. Transcatheter closure of perimembranous ventricular septal defects using the new amplatzer membranous VSD occluder: results of the U.S. phase I trial[J]. J Am Coll Cardiol, 2006, 47(2): 319-325.
doi: 10.1016/j.jacc.2005.09.028
|
[4] |
Quansheng X, Silin P, Zhongyun Z, et al. Minimally invasive perventricular device closure of an isolated perimembranous ventricular septal defect with a newly designed delivery system: Preliminary experience[J]. J Thorac Cardiovasc Surg, 2009, 137(3): 556-559.
doi: 10.1016/j.jtcvs.2008.05.073
pmid: 19258064
|
[5] |
Jiang D, Han B, Zhao L, et al. Transcatheter device closure of perimembranous and intracristal ventricular septal defects in children: medium- and long-term results[J]. J Am Heart Assoc, 2021, 10(11): e020417.
doi: 10.1161/JAHA.120.020417
|
[6] |
Li H, Shi Y, Zhang S, et al. Short- and medium-term follow-up of transcatheter closure of perimembranous ventricular septal defects[J]. BMC Cardiovasc Disord, 2019, 19(1): 222.
doi: 10.1186/s12872-019-1188-y
|
[7] |
Yang L, Tai BC, Khin LW, et al. A systematic review on the efficacy and safety of transcatheter device closure of ventricular septal defects (VSD)[J]. J Interv Cardiol, 2014, 27(3): 260-272.
doi: 10.1111/joic.12121
|
[8] |
Roos-Hesselink JW, Meijboom FJ, Spitaels SE, et al. Outcome of patients after surgical closure of ventricular septal defect at young age: longitudinal follow-up of 22-34 years[J]. Eur Heart J, 2004, 25(12): 1057-1062.
pmid: 15191777
|
[9] |
Oses P, Hugues N, Dahdah N, et al. Treatment of isolated ventricular septal defects in children: amplatzer versus surgical closure[J]. Ann Thorac Surg, 2010, 90(5): 1593-1598.
doi: 10.1016/j.athoracsur.2010.06.088
|
[10] |
张玉顺, 李寰, 刘建平, 等. 膜周部室间隔缺损介入治疗并发症的分析[J]. 中华儿科杂志, 2005, 43(1): 35-38.
|
[11] |
Manning PB. Ventricular septal defect closure: how I teach it[J]. Ann Thorac Surg, 2018, 106(2): 324-326.
doi: S0003-4975(18)30841-5
pmid: 29908192
|
[12] |
Dodge-Khatami A, Knirsch W, Tomaske M, et al. Spontaneous closure of small residual ventricular septal defects after surgical repair[J]. Ann Thorac Surg, 2007, 83(3): 902-905.
pmid: 17307430
|
[13] |
Zuo J, Xie J, Yi W, et al. Results of transcatheter closure of perimembranous ventricular septal defect[J]. Am J Cardiol, 2010, 106(7): 1034-1037.
doi: 10.1016/j.amjcard.2010.05.040
|
[14] |
Rahmath MR, Numan M, Dilawar M. Medium to long-term echo follow-up after ventricular septal defect device closure[J]. Asian Cardiovasc Thorac Ann, 2016, 24(5): 422-427.
doi: 10.1177/0218492316645746
|
[15] |
薛旺, 江江, 史承勇, 等. 室间隔缺损介入封堵和外科手术对瓣膜功能影响的对比研究[J]. 现代生物医学进展, 2016, 16(10): 1878-1883.
|
[16] |
Shah JH, Saraiya SP, Nikam TS, et al. Transcatheter device closure of perimembranous ventricular septal defect in pediatric patients: long-term outcomes[J]. Heart Views, 2020, 21(1): 17-21.
doi: 10.4103/HEARTVIEWS.HEARTVIEWS_13_19
|
[17] |
Haddad RN, Daou L, Saliba Z. Device Closure of perimembranous ventricular septal defect: choosing between amplatzer occluders[J]. Front Pediatr, 2019, 7: 300.
doi: 10.3389/fped.2019.00300
|
[18] |
严帆, 易岂建, 计晓娟, 等. 膜周部室间隔缺损经导管介入封堵后早期并发症危险因素的分析[J]. 中国循证儿科杂志, 2018, 13(5): 348-354.
|
[19] |
Santhanam H, Yang L, Chen Z, et al. A meta-analysis of transcatheter device closure of perimembranous ventricular septal defect[J]. Int J Cardiol, 2018, 254: 75-83.
doi: 10.1016/j.ijcard.2017.12.011
|
[20] |
Li Y, Hua Y, Fang J, et al. Identification of risk factors for arrhythmia post transcatheter closure of perimembranous ventricular septal defect[J]. J Invasive Cardiol, 2015, 27(8): E158-E166.
|
[21] |
Zhong QH, Zheng HY, Zhang ZW, et al. Prevalence and risk factors of arrhythmias after transcatheter closure of ventricular septal defect in children[J]. Chin J Cardiol, 2014, 42(10): 840-845.
|
[22] |
Li X, Li L, Wang X, et al. Clinical analysis of transcatheter closure of perimembranous ventricular septal defects with occluders made in China[J]. Chin Med J (Engl), 2011, 124(14): 2117-2122.
|
[23] |
Karadeniz C, Atalay S, Demir F, et al. Does surgically induced right bundle branch block really effect ventricular function in children after ventricular septal defect closure?[J]. Pediatr Cardiol, 2015, 36(3): 481-488.
doi: 10.1007/s00246-014-1037-9
pmid: 25293427
|
[24] |
Gholampour-Dehaki M, Zareh A, Babaki S, et al. Conduction disorders in continuous versus interrupted suturing technique in ventricular septal defect surgical repair[J]. Res Cardiovasc Med, 2016, 5(1): e28735.
|
[25] |
Xie L, Zhang H, Zhang R, et al. Management of late-onset complete atrioventricular block post transcatheter closure of perimembranous ventricular septal defects[J]. Front Pediatr, 2020, 7: 545.
doi: 10.3389/fped.2019.00545
|